High incidence of diaphragmatic myopotential oversensing by a specific implantable cardioverter defibrillator.

Baldinger, Samuel H; Haeberlin, Andreas; Servatius, Helge; Seiler, Jens; Noti, Fabian; Lam, Anna; Sweda, Romy; Reichlin, Tobias Roman; Tanner, Hildegard; Roten, Laurent (2020). High incidence of diaphragmatic myopotential oversensing by a specific implantable cardioverter defibrillator. Pacing and clinical electrophysiology, 43(2), pp. 234-239. Wiley 10.1111/pace.13864

Text Baldinger_et_al-2019-Pacing_and_Clinical_Electrophysiology.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (454kB) | Request a copy

INTRODUCTION

Diaphragmatic myopotential oversensing (dMPO) by implantable cardioverter defibrillators (ICDs) is thought to be a rare condition that can be misdiagnosed as lead failure and lead to unnecessary lead replacement. We observed several cases of dMPO in patients with Sorin/LivaNova ICDs (MicroPort Sci.). We sought to systematically assess the incidence of dMPO in patients with Sorin/LivaNova ICDs.

METHODS AND RESULTS

A predefined number of 100 consecutive patients with Sorin/LivaNova ICDs were prospectively included in the device clinic of our center. Stored arrhythmia episodes were checked for spontaneous dMPO. In addition, we performed provocation maneuvers by Valsalva. At least one episode of spontaneous or provoked dMPO was seen in 12 (12%) of the 100 patients included in the study (86% males, median age: 66 years). Nine of 89 patients (10%) with true bipolar and 3 of 11 patients (27%) with integrated bipolar sensing configuration were affected. Spontaneous dMPO was observed in 7 of 58 patients (12%) with sensitivity programmed to 0.4 mV and in 2 of 42 patients (5%) with sensitivity programmed to 0.6 mV (not significant). In three patients, dMPO could be provoked with no spontaneous episodes recorded. In two nonpacemaker-dependent patients with a CRT-D, ventricular pacing was temporarily inhibited. No antitachycardia therapy was triggered by dMPO in any patient.

CONCLUSIONS

DMPO is frequent in patients with Sorin/LivaNova ICDs, especially with sensitivity programmed to 0.4 mV. It also frequently occurs with true bipolar sensing configuration. DMPO should not be misinterpreted as lead failure to avoid unnecessary lead replacement.

Interest & Impact

Downloads

2 since deposited on 23 Jan 2020
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item